285 related articles for article (PubMed ID: 17125432)
1. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment.
Moffett BS; Cannon BC; Friedman RA; Kertesz NJ
Pharmacotherapy; 2006 Dec; 26(12):1687-93. PubMed ID: 17125432
[TBL] [Abstract][Full Text] [Related]
2. Enoxaparin use in the neonatal intensive care unit: experience over 8 years.
Malowany JI; Knoppert DC; Chan AK; Pepelassis D; Lee DS
Pharmacotherapy; 2007 Sep; 27(9):1263-71. PubMed ID: 17723080
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances.
Bauer LA; Black DJ; Lill JS; Garrison J; Raisys VA; Hooton TM
Antimicrob Agents Chemother; 2005 Apr; 49(4):1649-51. PubMed ID: 15793163
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic monitoring and pharmacokinetic evaluation of procainamide in neonates.
Bryson SM; Leson CL; Irwin DB; Trope AE; Hosking MC
DICP; 1991 Jan; 25(1):68-71. PubMed ID: 2008787
[TBL] [Abstract][Full Text] [Related]
5. Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
Bauer LA; Black D; Gensler A; Sprinkle J
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):213-6. PubMed ID: 2472362
[TBL] [Abstract][Full Text] [Related]
6. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.
Stiell IG; Clement CM; Symington C; Perry JJ; Vaillancourt C; Wells GA
Acad Emerg Med; 2007 Dec; 14(12):1158-64. PubMed ID: 18045891
[TBL] [Abstract][Full Text] [Related]
7. [Steady-state plasma and saliva concentrations of procainamide and N-acetyl-procainamide after a sustained release preparation].
Pirovino M; Karlaganis G; Galeazzi RL
Schweiz Med Wochenschr; 1980 Sep; 110(39):1415-9. PubMed ID: 6169144
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
Mehrotra N; Tang L; Phelps SJ; Meibohm B
Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
[TBL] [Abstract][Full Text] [Related]
9. [Verification of therapeutic levels of procainamide and N-acetyl- procainamide in ventricular arrhythmia].
Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A; Makuch K; Romański B
Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):458-60. PubMed ID: 1703654
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation.
van der Vorst MM; Wildschut E; Houmes RJ; Gischler SJ; Kist-van Holthe JE; Burggraaf J; van der Heijden AJ; Tibboel D
Crit Care; 2006; 10(6):R168. PubMed ID: 17140428
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an open-loop, computer-based infusion system designed to achieve a series of constant, targeted plasma procainamide concentrations in patients undergoing electrophysiologic testing.
Coyle JD; Carnes CA; Schaal SF
Pharmacotherapy; 1997; 17(3):445-56. PubMed ID: 9165549
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans.
Tisdale JE; Rudis MI; Padhi ID; Svensson CK; Webb CR; Borzak S; Ware JA; Krepostman A; Zarowitz BJ
J Clin Pharmacol; 1995 Sep; 35(9):902-10. PubMed ID: 8786250
[TBL] [Abstract][Full Text] [Related]
13. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age.
van den Anker JN; Schoemaker RC; Hop WC; van der Heijden BJ; Weber A; Sauer PJ; Neijens HJ; de Groot R
Clin Pharmacol Ther; 1995 Dec; 58(6):650-9. PubMed ID: 8529330
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of amikacin in preterm and term infants.
Siddiqi A; Khan DA; Khan FA; Razzaq A
Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
[TBL] [Abstract][Full Text] [Related]
15. Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated.
Rocci ML; Kosoglou T; Ferguson RK; Vlasses PH
J Pharmacol Exp Ther; 1989 Mar; 248(3):923-8. PubMed ID: 2467982
[TBL] [Abstract][Full Text] [Related]
16. [Tolerability of once-daily-dosing of intravenous gentamicin in preterm neonates born at 32-37 weeks of gestation].
Miron D; Steinfeld M; Hasanein J; Felszer C; Reich D
Harefuah; 2003 Jun; 142(6):413-5, 487. PubMed ID: 12858823
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide.
Vlasses PH; Kosoglou T; Chase SL; Greenspon AJ; Lottes S; Andress E; Ferguson RK; Rocci ML
Arch Intern Med; 1989 Jun; 149(6):1350-3. PubMed ID: 2471472
[TBL] [Abstract][Full Text] [Related]
18. Once daily gentamicin dosing in full term neonates.
Alsaedi SA
Saudi Med J; 2003 Sep; 24(9):978-81. PubMed ID: 12973482
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic comparisons of twice daily and four times daily formulations of procainamide in patients with frequent ventricular premature depolarization.
Yang BB; Abel RB; Uprichard AC; Smithers JA; Forgue ST
J Clin Pharmacol; 1996 Jul; 36(7):623-33. PubMed ID: 8844445
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of continuous infusion fentanyl in newborns.
Santeiro ML; Christie J; Stromquist C; Torres BA; Markowsky SJ
J Perinatol; 1997; 17(2):135-9. PubMed ID: 9134513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
